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Abstract
Nasal and pharyngeal swabs were collected from 132 patients
admitted to the Principal Hospital in Dakar (Senegal), in January
and February 2012. The prevalence of Staphylococcus aureus
carriage was 56.1% (n = 74): 40.2% for pharyngeal samples and
36.4% for nasal samples. None of the isolates was methicil-
lin-resistant. Carriage was independently associated with being
female (p <0.01) and large households (≥15 members) (p 0.04).
The luk-PV genes encoding Panton–Valentine leukocidin (PVL)
were present in 26.2% of the isolates. These data highlight the
importance of the oropharynx as a site of colonization, and the
high prevalence of PVL-positive isolates in Senegal as compared
with industrialized countries.
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Staphylococcus aureus remains a major human pathogen [1].
Colonization of the anterior nares is considered to be the
most important risk factor for S. aureus infection, and decol-
onization is recommended in certain speciﬁc populations at
risk of infection in developed countries [2]. Recent studies
have identiﬁed the oropharynx as an unrecognized and
underestimated site of colonization [3–5]. This has potentially
major implications for decolonization strategies [2], as topical
agents for eradicating nasal colonization are unlikely to affect
throat carriage [6]. We report here the prevalence and risk
factors of S. aureus carriage, antimicrobial drug susceptibility
and the molecular characterization of isolates in patients
admitted to the emergency department of the Principal
Hospital, Dakar, Senegal (West Africa).
Nasal and pharyngeal swabs were collected from patients
recruited at random, on 2 days per week, within 2 h of their
admission in January and February 2012. None of the patients
showed skin and soft tissue infection at inclusion. A standard-
ized speciﬁc questionnaire was completed, for the collection of
demographic data, medical history over the previous
12 months, and information concerning risk factors for
nasopharyngeal carriage (Table 1). The Senegalese national
ethics committee approved the study protocol.
The swabs were placed at +4°C immediately after sampling,
and were processed within 4 h. They were used to inoculate a
pre-enrichment medium consisting of brain–heart broth con-
taining 7.5% NaCl. After incubation overnight at 37°C in
aerobic conditions, selective enrichment was carried out in
brain–heart broth (BioMerieux, Marcy l’Etoile, France) sup-
plemented with colistin (4 mg/L). We used 25 lL of the
selective enrichment broth to inoculate speciﬁc agar plates
(BBL CHROMagar S. aureus and BBL CHROMagar MRSA;
Becton Dickinson, Heidelberg, Germany). S. aureus identiﬁca-
tion, antimicrobial susceptibility by the disk diffusion method in
accordance with the guidelines of the French Society for
Microbiology (see CA-SFM guidelines: http://www.sfm-micro-
biologie.org), genomic extraction, multiplex PCR ampliﬁcation
of the agr locus for conﬁrmation of the identiﬁcation, screening
for luk-PV genes, spa typing and multilocus sequence typing
(MLST) were performed as previously described [7–9]. MLST
was performed on one strain randomly selected for each of
the spa types identiﬁed.
The chi-square test and Student’s t-test were used to
compare categorical and continuous variables in univariate
analysis, respectively, with R software. Factors with p-values of
<0.20 in univariate analysis were retained for multivariate
analysis. We considered p-values of <0.05 to indicate signif-
icant associations.
In total, 132 patients (63 female/69 male; mean age,
38 years; median age, 41.3 years) of Senegalese origin were
included. Seventy-four (56.1%) were carrying S. aureus (44
female/30 male; mean age, 39.3 years; median age, 38 years;
interval range, 11–84 years; 25th percentile, 25.3 years; 75th
percentile, 50.8 years). The overall prevalence of carriage in
the nose and/or throat (74/132, 56.1%) and of carriage in the
throat (53/132, 40.2%) was consistent with the few studies that
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have reported and compared nasal and pharyngeal carriage
(49.9–57.8% and 34.7–44%, respectively) [3–5]. Nasal carriage
of S. aureus was reported in 36.4% (48/132) of those tested.
This value is in the middle of the range of reported values
(14.0–55.1%) [2]. Carriage was exclusively pharyngeal in 26
patients (19.7%), exclusively nasal in 21 (15.9%), and concerned
both sites in 27 (36.5%).
Large households (≥15 members) were borderline signiﬁ-
cantly associated with an enhanced risk of S. aureus carriage
(p 0.04) in our study, as previously described [2]. Men have
repeatedly been reported to have a higher incidence of
carriage in several populations and settings [4], whereas we
found an association between carriage and being female
(p <0.01) (Table 1). Further investigations with a larger cohort
of patients are needed to conﬁrm these results.
One colony from each site positive for S. aureus was
investigated by spa typing. Overall, the 101 S. aureus isolates
belonged to 42 spa types, which were separated by the Based
Upon Repeat Pattern algorithm into 11 spa clonal complexes
(CCs) and six singletons (groups represented by a single spa
type). Each spa CC corresponded to a single MLST CC. CC
variability in the throat was similar to that in the nose
(Table 2). Twenty-one (77.7%) of the 27 patients showing
both nasal and pharyngeal colonization had identical isolates
at both sites, as demonstrated on the basis of spa types. In
such cases, only one isolate per patient was retained for
further analyses (80 isolates in total). None of the isolates
was methicillin-resistant. They showed susceptibility to most
of the antibiotics tested, except for penicillin G (87.5% of
resistant isolates), co-trimoxazole (50.0%), and tetracycline
(27.5%). Seventy-one per cent (n = 57) clustered into ﬁve
main MLST CCs: CC15 (21.3%), CC8 (15.0%), CC5 (16.3%),
CC152 (10.0%), and CC45 (8.8%) (Table 2). Seven of the 11
CCs found in our study, including four of the ﬁve major CCs,
have been identiﬁed as successful genetic backgrounds for
methicillin-resistant S. aureus, suggesting that they may pro-
vide a stable genetic environment for SCCmec integration.
They have been found worldwide (CC1, CC8, CC30, CC45,
and CC152) [1] or more speciﬁcally in Dakar (CC5) or Africa
(CC88) [9]. It is therefore important to continue the
TABLE 1. Risk factors associated with Staphylococcus aureus carriage in 132 patients
Carriage (n = 74) Non-carriage (n = 58)
Univariate analysis Multivariate analysis
Crude OR p-value Adjusted OR 95% CI p-value
Mean age in years (95% CI) 39.3 (39.2–39.5) 43.7 (43.6–43.8) – 0.13 0.98 0.96–1.01 0.23
Female gender, n (%) 44 (70) 19 (30) 2.9 0.003 3.0 1.4–6.6 <0.01
Underlying chronic disease, n (%) 25 (52) 14 (48) 1.6 0.25 – – –
Hospitalization in the last 12 months, n (%) 11 (69) 5 (31) 1.8 0.29 – – –
Surgery in the last 12 months, n (%) 4 (80) 1 (20) 3.3 0.38 – – –
Skin and soft tissue infection in the last 12 months, n (%) 11 (79) 3 (21) 3.3 0.09 3.5 0.9–14.2 0.08
Antibiotic treatment in the last 3 months, n (%) 25 (61) 16 (39) 1.5 0.34 – – –
Family healthcare worker, n (%) 16 (61) 10 (39) 1.3 0.66 – – –
Smoker, n (%) 3 (27) 8 (73) 0.27 0.06 0.22 0.03–1.4 0.10
≥15 household members, n (%) 16 (73) 6 (27) 2.5 0.09 3.2 1.1–9.9 0.04
TABLE 2. Molecular characteristics of methicillin-susceptible Staphylococcus aureus isolates from nasal and pharyngeal swabs
collected from 74 carriers in Dakar, Senegal
MLST Nasal strains Pharyngeal strains Total
CC ST spa-types (n) luk-PV (%) Total spa-types (n) luk-PV n (%) Total Strains n (%) Patientsa n (%)
15 15 084 (10) 3 (30) 10 084 (9), 279 (1), 491 (1), 774 (1) 3 (25) 12 22 (22) 17 (21)
8 8 1476 (4), 2555 (1), 451 (1) 1 (17) 6 451 (2), 2555 (1), 1476 (2), 451 (1), 8 (1) 0 7 13 (13) 11 (14)
1404 0 0 1617 (1) 0 1 1 (1) 1 (1)
5 5 311 (8), 062 (1) 1 (11) 9 311 (4) 0 4 13 (13) 13 (16)
45 508 861 (4), 1510 (2), 3986 (2) 0 8 1510 (1), 10429 (1), 10430 (1) 0 3 11 (11) 7 (9)
152 152 4235 (3), 4690 (1) 3 (75) 4 355 (2), 1172 (1), 4235 (1) 4 (100) 4 8 (8) 6 (7)
377 5129 (1) 1 (100) 1 5129 (1) 1 (100) 1 2 (2) 2 (3)
121 121 314 (3) 3 (100) 3 314 (3) 3 (100) 3 6 (6) 3 (4)
30 30 276 (1), 012 (1) 2 (100) 2 012 (3) 2 (67) 3 5 (5) 4 (5)
97 97 267 (1), 359 (1) 0 2 267 (1) 0 1 3 (3) 2 (3)
80 80 0 0 5802 (1), 131 (1) 0 2 2 (2) 2 (3)
1 852 5500 (1), 127 (1) 0 2 0 2 (2) 2 (3)
88 88 0 0 692 (1) 0 1 1 (1) 1 (3)
b 7760 (2), 091 (1), 1458 (1),
10426 (1), 10427 (1)
2 (29) 7 091 (1), 100 (1), 8481 (1) 0 3 10 (1) 9 (11)
c 0 0 635 (1), 1991 (1) 2 (100) 2 2 (2) 0
Total 16 (30) 54 15 (32) 47 101 (100) 80 (100)
MLST, multilocus sequence typing; CC, clonal complex; ST, sequence type.
aFor patients displaying both nasal and pharyngeal colonization, only one of the identical spa-type paired isolates was retained for subsequent analysis (in all, 80 strains).
bspa CCs with no founder.
cSingleton spa types shorter than ﬁve repeats.
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monitoring of antimicrobial susceptibility in clinical S. aureus
isolates.
The luk-PV genes encoding Panton–Valentine leukocidin
(PVL) were present in 22.6% of the isolates, belonging to 15
(35.7%) of the 42 spa types. PVL prevalence in S. aureus
isolates from carriage is highly variable worldwide [10]. There
may be a gradient, with the prevalence of these isolates
decreasing from West and Central Africa (Senegal (present
study); Mali, >35% [11]; Gabon, 56% [12]) to North Africa
(Algeria, 9%) [13] and Europe (0.3–1.4%) [14]. The reasons for
such a high prevalence remain unclear, but the high virulence
of these S. aureus isolates [15,16], together with factors
speciﬁcally associated with developing countries (e.g. poor
access to healthcare services, poor hygiene and sanitary
conditions, and overcrowding, etc.), may increase the risk of
inter-individual transmission [17].
In conclusion, our data highlight the importance of the
oropharynx as a site of colonization, and the high prevalence of
PVL-positive isolates in strains from Senegal.
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